Skip to main content
OpenTrials
Completed

NCT Number: NCT04433325

COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units

Since early 2020, France knows a sanitary crisis with a massive influx of COVID-19 patients admitted in Intensive Care Units (ICU). It led to a saturation of the French health system, especially in some geographic areas such as East of France or Paris region. Therefore, authorities decided to transfer some critically ill patients from these crowded ICUs to less busy regional ICUs. it was done for the first time by medical train transportation. Knowing that the investigators lack experience regarding this type of medical evacuation, regarding the high number of transferred patients, with such a logistic effort, the investigators decided to study this phase of the COVID-19 sanitary crisis in order to draw a feedback. So far, there are no data in the literature regarding this topic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Intensive Care Unit Syndrome Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Poitiers, Poitiers, France

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years
  • COVID-19 positive patients admitted in Intensive Care Unit between 15/03/2020 and 15/04/2020
  • Patients (or legal representative) with no opposition to inclusion in medical research protocol
  • Regarding case group : Patients transferred from Paris's ICU
  • Regarding case control group : Patients admitted in ICU with no transfer from Paris

Exclusion criteria

  • > 18 years under legal protection and patients with liberty restriction

Treatment and study plan

Primary outcomes

  1. number of death

    Time frame: at Intensive Care Units discharge, an average of 1 months

    to evaluate mortality

Secondary outcomes

  1. number of infections

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

    to evaluate morbidity

  2. number of days of mechanical ventilation

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

  3. number of days of sedation

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

  4. number of days of use of neuromuscular blocking agents

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

  5. number of days of vasopressor use

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

  6. number of days in Intensive Care Units

    Time frame: from date of admission until Intensive Care Units discharge, assessed up to 1 months

  7. number of days in hospital

    Time frame: from date of admission until hospital discharge, assessed up to 1 months

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Acronym: TOCCIP

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 16, 2020
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.